Human Papillomavirus
Human papillomavirus vaccination utilizes recombinant adeno-associated virus
Published in Women's Health Weekly, May 8th, 2006
"AAV have been developed and evaluated as recombinant vectors for gene therapy in many preclinical studies, as well as in clinical trials. However, only a few approaches have used rAAV to deliver vaccine antigens," wrote D. Kuck and colleagues, German Cancer Research Center.
"We generated an rAAV encoding the major capsid protein L1 (L1h) from the human papillomavirus type 16 (HPV16), aiming to develop a prophylactic vaccine against HPV16 infections, which are the major cause of cervical cancer in women worldwide. A single...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Behavioral Medicine
Cortical thickness differences in men and women may influence gender-specific abilities - Breast Cancer
Breast screening radiation has been re-evaluated for risk estimate based on current data - Coronary Heart Disease
Risk of sudden cardiac death in women may be reduced by regular physical exercise - Obesity Surgery
Weight loss after laparoscopic adjustable gastric banding improves metabolic profile - Substance Abuse
Alcohol and substance abuse relapse reveals gender responses to interpersonal problems - Apoptosis
Reports from India, Iran and Australia describe recent advances in apoptosis research - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
